BPA Call 36C24821A0045-36C24822K0001
- This is a firm fixed-price contract awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a division of the global healthcare company Abbott Laboratories. The contract is for the delivery of blood glucose monitoring supplies to support VA healthcare services for the month of October 2021, with a total ceiling value of $9,945.00. The contract is a Blanket Purchase Agreement (BPA) call under Abbott Laboratories...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc. for the supply of blood glucose monitoring supplies for the months of November 2022 to February 2023. The contract, which has a ceiling value of $6,763.50, was awarded on November 8, 2022, and is scheduled for completion on February 26, 2023. The contract was placed under the GSA...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs to Abbott Laboratories Inc. for $12,150.00 to provide blood glucose monitoring supplies for the month of August 2021. The contract is under the GSA Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Test. No set-aside designation was used. The contract enables the VA to efficiently procure critical medical supplies for VA healthcare facilities through an existing IDV contract...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company that specializes in manufacturing medical devices, diagnostic equipment, and pharmaceuticals. The contract is for the express delivery of blood glucose monitoring supplies for the months of May 2023 through August 2023, with a ceiling value of $24,111.00. The contract was awarded under the VA's In-Vitro Diagnostics, Reagents,...
- This is a Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a division of the global healthcare company Abbott Laboratories. The $7,285.50 contract is for the delivery of blood glucose monitoring supplies to support VA healthcare services from September 2022 through December 2022. The award was placed against Abbott's existing GSA Schedule contract for In-vitro Diagnostics, Reagents, and Test Kits, which allows VA...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call issued by the Veterans Integrated Service Network 8 (VISN 8) for blood glucose monitoring supplies to be delivered from October 2023 through April 2024. The total ceiling value of the order is $53,460.00. The contract was awarded to Abbott Laboratories Inc., a global healthcare company that specializes in manufacturing medical devices, diagnostic equipment, and pharmaceuticals. This BPA call is likely part of a larger Indefinite...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company that manufactures medical devices, diagnostic equipment, and pharmaceuticals. The contract, with a ceiling value of $8,280.00, is for the provision of blood glucose monitoring supplies for the VA from February 2023 to May 2023. The BPA was established under the VA's GSA Schedule 65-VII for In-Vitro Diagnostics, Reagents,...
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company, for the provision of blood glucose monitoring supplies. The contract, valued at $29,700.00, is a Blanket Purchase Agreement (BPA) call order under the VA's existing General Services Administration (GSA) Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Test. The contract period of performance is from April 2022 to October 2022 and does not utilize...
- This is a $18,450.00 Firm Fixed Price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc. for the provision of blood glucose monitoring supplies during the months of October through December 2024. The contract is a call order under Abbott's existing General Services Administration (GSA) Schedule contract for In-Vitro Diagnostics, Reagents, and Test equipment (FSS-65-VII). The order will support the VA's regional Veterans...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc. to provide blood glucose monitoring supplies for the month of July 2024. The award amount is $23,100.00 and has no set-aside designation. This order is placed against Abbott Laboratories Inc.'s existing General Services Administration (GSA) Schedule contract for In-Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII), which allows the VA to...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- 36F79721D0079-36C24821A0045Blanket Purchase Agreement
- 36C24821A0045-36C24822K0001BPA Call
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 8 (VISN 8) to Abbott Laboratories Inc. for the provision of blood glucose monitoring supplies for the month of October 2021. The contract has a ceiling value of $7,350.00 and a performance period ending on November 22, 2021. The award was made under the General Services Administration (GSA) Federal Supply Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Test. No set-aside designation was used. As a global healthcare company, Abbott Laboratories Inc. is a significant federal contractor, particularly within the medical device and diagnostic equipment sectors, supporting the Department of Veterans Affairs and other federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 10/1/21 |